Home Compare BN.PA vs FME.DE
Stock Comparison · Valuation-led comparison

Danone vs Fresenius Medical Care: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Fresenius Medical Care carrying a narrow edge on valuation. Danone still has the edge on growth, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.

Updated 2026-05-17

The comparison is mainly decided in valuation, while growth remains the main counterforce.

Trajectory Similarity
0.74
Similar
Peer-set rank: #29
within Danone S.A.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

The match is driven mainly by margin consistency and investment intensity.

Similarity drivers
margin consistencyinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BN.PA
Danone S.A.
46
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
FME.DE
Fresenius Medical Care AG
47
Peer-Score
Signal qualitylow
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing shapes this comparison more than a broad operating gap.

Dimension spread: BN.PA vs FME.DE Profitability 34 25 Stability 58 51 Valuation 52 85 Growth 44 18 BN.PA FME.DE
Gap Ranking
#1 Valuation +33
#2 Growth +26
#3 Profitability +9
#4 Stability +7
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BN.PA and FME.DE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BN.PAFME.DE Relative valuation Structural strength

Danone S.A. looks stronger, but the price setup still looks more supportive for Fresenius Medical Care AG.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where BN.PA and FME.DE each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY BN.PA Elevated · below norm 0th 50th 100th 38 pct gap FME.DE Neutral · below norm 0th 50th 100th 72nd 34th
Today FME.DE sits in the lower-middle of its own 5-year history (34th percentile), while BN.PA sits higher in its own history (72nd). Within each stock's own 5-year context, FME.DE is at a historically more favourable entry position than BN.PA. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Valuation
Both profiles are strong on valuation, but Fresenius Medical Care AG leads clearly.
Growth
Danone S.A. sits higher in the group on growth, adding to the overall structural advantage.
Valuation — Dominant Gap
BN.PA
52
FME.DE
85
Gap+33in favour of FME.DE

The multiple-based pricing edge comes from a forward P/E that is 6.2 turns lower.

What keeps the gap from being one-sided

There is still a strong counterforce in growth, so the lead stays clear without becoming a sweep.

What this means for the comparison

The main read on valuation is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the BN.PA vs FME.DE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BN.PA and FME.DE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.